DYNAVAX TECHNOLOGIES CORP

CUSIP: 268158201 Class: Common Stock

Bain Capital Life Sciences Investors, LLC's Holding History (CIK: 0001703031)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 915,000 Value ($000) $13,515 Avg Close Range
Q2 2023
Shares 2,415,000 Value ($000) $31,202 Avg Close Range
Q1 2023
Shares 3,915,000 Value ($000) $38 Avg Close Range
Q4 2022
Shares 3,915,000 Value ($000) $42 Avg Close Range
Q3 2022
Shares 5,415,000 Value ($000) $56,533 Avg Close Range
Q2 2022
Shares 8,415,000 Value ($000) $105,945 Avg Close Range
Q1 2022
Shares 8,415,000 Value ($000) $91,219 Avg Close Range
Q4 2021
Shares 8,415,000 Value ($000) $118,399 Avg Close Range
Q3 2021
Shares 8,415,000 Value ($000) $161,652 Avg Close Range
Q2 2021
Shares 11,771,708 Value ($000) $115,951 Avg Close Range
Q1 2021
Shares 10,895,773 Value ($000) $107,105 Avg Close Range
Q3 2020
Shares 10,895,773 Value ($000) $47,070 Avg Close Range
Q2 2020
Shares 10,895,773 Value ($000) $96,646 Avg Close Range
Q1 2020
Shares 8,730,707 Value ($000) $30,819 Avg Close Range
Q4 2019
Shares 8,452,235 Value ($000) $48,347 Avg Close Range
Q3 2019
Shares 8,452,235 Value ($000) $30,259 Avg Close Range